Experience with basiliximab in pediatric renal transplantation

Transplant Proc. 2002 Feb;34(1):100-1. doi: 10.1016/s0041-1345(01)02686-0.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / therapeutic use*
  • Basiliximab
  • Child
  • Cyclosporine / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Graft Rejection / epidemiology
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Isoantibodies / blood
  • Kidney Transplantation / immunology*
  • Lymphocytes / immunology
  • Male
  • Methylprednisolone / therapeutic use
  • Receptors, Interleukin-2 / analysis
  • Recombinant Fusion Proteins*
  • Renal Dialysis
  • Reoperation
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Isoantibodies
  • Receptors, Interleukin-2
  • Recombinant Fusion Proteins
  • Cyclosporine
  • Basiliximab
  • Methylprednisolone